Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004

Completed · Phase 4

Conditions studied: Giant Cell Tumor of Bone

In brief

Study 20140114 will continue to follow participants with GCTB who were treated in Study 20062004 and remained on the study at the completion of Study 20062004 for an additional 5 years on long-term safety follow up.

Key facts

Study ID
NCT03301857
Run by
Amgen
People needed
85
Starts
2017-11-13
Expected to finish
2023-07-27
Last updated by the study team
2024-05-20

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.